These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

618 related articles for article (PubMed ID: 28265539)

  • 1. Blood-brain barrier transport machineries and targeted therapy of brain diseases.
    Barar J; Rafi MA; Pourseif MM; Omidi Y
    Bioimpacts; 2016; 6(4):225-248. PubMed ID: 28265539
    [No Abstract]   [Full Text] [Related]  

  • 2. Impacts of blood-brain barrier in drug delivery and targeting of brain tumors.
    Omidi Y; Barar J
    Bioimpacts; 2012; 2(1):5-22. PubMed ID: 23678437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Getting into the brain: approaches to enhance brain drug delivery.
    Patel MM; Goyal BR; Bhadada SV; Bhatt JS; Amin AF
    CNS Drugs; 2009; 23(1):35-58. PubMed ID: 19062774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain penetrating peptides and peptide-drug conjugates to overcome the blood-brain barrier and target CNS diseases.
    Zhou X; Smith QR; Liu X
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jul; 13(4):e1695. PubMed ID: 33470550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting receptor-ligand chemistry for drug delivery across blood-brain barrier in brain diseases.
    Anthony DP; Hegde M; Shetty SS; Rafic T; Mutalik S; Rao BSS
    Life Sci; 2021 Jun; 274():119326. PubMed ID: 33711385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood-brain barrier drug discovery for central nervous system infections.
    Jong A; Huang SH
    Curr Drug Targets Infect Disord; 2005 Mar; 5(1):65-72. PubMed ID: 15777199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier.
    Sharma G; Sharma AR; Lee SS; Bhattacharya M; Nam JS; Chakraborty C
    Int J Pharm; 2019 Mar; 559():360-372. PubMed ID: 30721725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo biodistribution of prion- and GM1-targeted polymersomes following intravenous administration in mice.
    Stojanov K; Georgieva JV; Brinkhuis RP; van Hest JC; Rutjes FP; Dierckx RA; de Vries EF; Zuhorn IS
    Mol Pharm; 2012 Jun; 9(6):1620-7. PubMed ID: 22536790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro blood-brain barrier models for drug screening and permeation studies: an overview.
    Bagchi S; Chhibber T; Lahooti B; Verma A; Borse V; Jayant RD
    Drug Des Devel Ther; 2019; 13():3591-3605. PubMed ID: 31695329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug delivery to brain via the blood-brain barrier.
    Scherrmann JM
    Vascul Pharmacol; 2002 Jun; 38(6):349-54. PubMed ID: 12529929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases.
    Löscher W; Potschka H
    Prog Neurobiol; 2005 May; 76(1):22-76. PubMed ID: 16011870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nano carriers for drug transport across the blood-brain barrier.
    Li X; Tsibouklis J; Weng T; Zhang B; Yin G; Feng G; Cui Y; Savina IN; Mikhalovska LI; Sandeman SR; Howel CA; Mikhalovsky SV
    J Drug Target; 2017 Jan; 25(1):17-28. PubMed ID: 27126681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Delivery Strategies to Overcome the Blood-Brain Barrier (BBB).
    Helms HCC; Kristensen M; Saaby L; Fricker G; Brodin B
    Handb Exp Pharmacol; 2022; 273():151-183. PubMed ID: 33367937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The barrier and interface mechanisms of the brain barrier, and brain drug delivery.
    Zhang S; Gan L; Cao F; Wang H; Gong P; Ma C; Ren L; Lin Y; Lin X
    Brain Res Bull; 2022 Nov; 190():69-83. PubMed ID: 36162603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood-brain barrier models: in vitro to in vivo translation in preclinical development of CNS-targeting biotherapeutics.
    Stanimirovic DB; Bani-Yaghoub M; Perkins M; Haqqani AS
    Expert Opin Drug Discov; 2015 Feb; 10(2):141-55. PubMed ID: 25388782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents.
    Cho CF; Wolfe JM; Fadzen CM; Calligaris D; Hornburg K; Chiocca EA; Agar NYR; Pentelute BL; Lawler SE
    Nat Commun; 2017 Jun; 8():15623. PubMed ID: 28585535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A perfused human blood-brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport.
    Wevers NR; Kasi DG; Gray T; Wilschut KJ; Smith B; van Vught R; Shimizu F; Sano Y; Kanda T; Marsh G; Trietsch SJ; Vulto P; Lanz HL; Obermeier B
    Fluids Barriers CNS; 2018 Aug; 15(1):23. PubMed ID: 30165870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticles as Powerful Tools for Crossing the Blood-brain Barrier.
    Hasannejad-Asl B; Pooresmaeil F; Choupani E; Dabiri M; Behmardi A; Fadaie M; Fathi M; Moosavi SA; Takamoli S; Hemati E; Naei VY; Kazemi-Lomedasht F
    CNS Neurol Disord Drug Targets; 2023; 22(1):18-26. PubMed ID: 35196974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development.
    Ohtsuki S; Terasaki T
    Pharm Res; 2007 Sep; 24(9):1745-58. PubMed ID: 17619998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mfsd2a-based pharmacological strategies for drug delivery across the blood-brain barrier.
    Wang JZ; Xiao N; Zhang YZ; Zhao CX; Guo XH; Lu LM
    Pharmacol Res; 2016 Feb; 104():124-31. PubMed ID: 26747400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.